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LEVINE, A S ,  M GRACE, C J BILLINGTON, B A GOSNELL, D D KRAHN, D M BROWN AND J E 
MORLEY Effect of morphine and nalrnefene on energy balance m dtabetw and non-dtabetw rats PHARMACOL 
BIOCHEM BEHAV 29(3)495-500, 1988 --Male rats made dmbetlc by intravenous rejection of streptozotocm were used to 
evaluate the effect of the dmbetlc state on morphine- and nalmefene-mduced changes m food retake and body weight 
Morphme mcreased 4 hour food retake m non-dmbet~c rats after an initial rejection, but increased intake in diabetic rats 
only after repeated rejections Unhke short term measurements, morphine decreased food intake when measured over 24 or 
more hours in both groups Chronic rejection of morphine decreased body weight only m non-diabetic rats Feed efficiency 
data suggest that morphine had a more potent effect on energy balance m the non-dlabet~c rats The oplold antagomst, 
nalmefene, did not alter body weight in either group and only altered food intake m the diabetic animals These data are m 
concert w~th other reports indicating that the diabetic state renders animals less responsive to the effects of morphine on 
noocept~on and smooth muscle contraction 
Oplolds Dmbetes Morphine Nalmefene 
G L U C O S E  has been shown to modulate the responsiveness 
of laboratory ammals to oplold effects In 1956 Davis et al 
[3] found that hypoglycemia potentiated the antlnoclceptlve 
action of  morphine in rats as quantified by the tall flick 
method Simon et al [29,30] demonstrated that the analgesic 
effects of morphine, phenazoclne and levorphanol were de- 
creased in rats made diabetic by injection of streptozotocln 
Pretreatment with hypertonlc dextrose or fructose produced 
the same effect [29,30] Shook et al [28] also reported that 
increasing the concentration of glucose in the media reduced 
the responsivlty of the electrically stimulated ileum to nor- 
morphine which suggests that glucose concentration, rather 
than insulin alteration, is the mediator of  their m VlVO find- 
ings Recently, Shook and Dewey [27] found that diabetic 
mice were less physically dependent upon morphine than 
non-diabetic controls Genetically diabetic mice display In- 
creased tall flick latencies to radiant heat relative to their 
httermate controls [9] Both diabetic patients and subjects 
refused with glucose had decreased pain thresholds and pmn 
tolerance [22] 
Since it 1s known that glucose levels or glucose utlhzatlon 
can modulate feeding behavior, that opioids can stimulate 
food intake [7,21] and that glucose modulates oploid 
noclceptlve effects, ~t seems reasonable to believe that glu- 
cose might modulate oplold effects on food intake Our lab- 
oratory found that both genetically diabetic mice (C57 
BL/Ks-db+/db+)  and streptozotocln dtabetlc mice show en- 
hanced sensitivity to naloxone-lnduced suppression of  food 
intake [6] Rats made hypoglycemlc by injection of lnsuhn, a 
procedure that sttmulates food intake, are relatively insensi- 
tive to naloxone diminution of food intake [5,10], however, 
this may depend upon the environment in which the study IS 
conducted [25] In general, then, it appears that elevated 
glucose levels potentiate the naloxone effect, although we 
have found this to be markedly influenced by the animal's 
environment [8] 
Data concerning long term administration of oplold 
agonlsts and antagonists on food intake and body weight are 
few and confusing Chronic naltrexone infusions decreased 
food Intake in rats fed chow plus a 32% sucrose solution 
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better than m those ingesting only chow [16] Repeated ln- 
jectmns of a zinc tannate preparatmn of naloxone decreased 
food retake only In rats receiving a high fat cafeteria diet [15] 
In a group of lean and obese Zucker rats, the long-acting 
oplold antagonist, nalmefene (6-desoxy-6 methylene nal- 
trexone), decreased food intake but only slightly altered 
body weight [ll,12] On the other hand it has been reported 
that mice gain weight when g~ven naloxone and decrease their 
food retake after chromc morphine administration [26] In 
long term studies m humans naltrexone has been shown to 
shghtly decrease or have no effect on body weight [1,17] 
The effect of chromc admlmstratlon of oplolds and their 
antagonists on food mtake and body weight m dmbetlc vs 
non-dmbetlc rats Is not known In the present study we ad- 
dressed this issue by injecting the oplold agonlst, morphine, 
and the oplold antagonist, nalmefene, in a group of 
streptozotocm-lnduced dmbet~c rats and non-dmbet~c rats of 
the same strain for a period of 24 days while measuring food 
intake and body weight Nalmefene is potent and long lived 
relative to naloxone and does not possess as much oplold 
agonlst activity as naloxone [4] 
METHOD 
Male Sprague-Dawley rats were used for all studies and 
were housed under standard hghtlng and temperature condi- 
tions (12 hour/day artificml hght, 7 a m. to 7 p m , 25°C) 
Animals were gwen free access to Purina laboratory chow 
and to water At about 7 weeks of age rats were given an 
intravenous inJection (tad veto) of streptozotocln (55 mg/kg 
m 1 3% citric acid buffer, pH 4 5) followed by 2 ml of 30% 
dextrose Three weeks later they were bled vm the tail veto 
and glucose was measured using a Beckman Glucose 
Analyzer (Fullerton, CA) to assure a diabetic state (glu- 
cose=632+_22 mg/dl). Age-matched rats were used as 
non-diabetzc controls Food retake and body weight were 
quantified for 3 days before the start of the experimentation 
to acchmate the animals to handhng and daffy interruptions 
The rats were dlv]ded into five groups of ten and 1 group of 
eleven wh]ch allowed for three groups of dmbetlc and three 
groups of non-dmbetlc rats. To enable a balanced design for 
statistical analysis, one rat was omitted at random from the 
group containing eleven rats 
On day one of the study a single mject~on of either mor- 
phine sulfate (10 mg/kg, Eh Lilly and Co., Indmnapolls, IN), 
nalmefene (10 mg/kg, kindly prowded by Key Pharmaceuti- 
cals, I n c ,  Miami, FL) or vehicle was rejected subcutane- 
ously Food retake was then measured at hours 1, 2, 4, 6 and 
24. Durmg the ensuing 21 days, rats were reJected twice per 
day at about 0900 and 1600 hr On days 2 and 7 tood mtake 
was agam quantified at hours 1, 2, 4 and 6 (only 4 hour data 
are presented) Food retake and body weight were measured 
on days 3, 5, 10, 12, 15, 17, 19, and 22 Food intake was 
corrected for spdlage at each measurement and average dally 
intake was calculated by dividing the total food intake by the 
representative time period (eg grams eaten between (day 
3/day 5)/3) Ammals were sacrificed on day 24 following one 
rejection of the appropriate drug and trunk bood was col- 
lected for analysis of glucose with a glucose ox~dase proce- 
dure (S~gma Chemical Co., St Lores, MO) 
All data are shown as mean+_SEM Data were analyzed 
by analys~s of variance (ANOVA) (repeated measures when 
appropriate). Post-hoc tests (least s~gmficant dtfference 
procedure-LSD) were only conducted ff the overall ANOVA 
demonstrated an interaction The error term for each post- 
hoc test was calculated by a one factor ANOVA 
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FIG 1 The effect of morphine (10 mg/kg bid) and nalmefene (10 
mg/kg bid) on 4 hour food retake in diabetic (D) and non-dmbetlc 
(ND) rats on days 1, 2 and 7 of the study *p<0 05 compared to 
sahne controls for rats of same day and dmbetlc status 
RESULTS 
At sacrifice, trunk blood was sampled and serum was 
analyzed for glucose concentration Serum glucose levels in 
diabetic and non-diabetic animals were not altered following 
chronic injections of morphine or nalmefene (DlabeUc 
sahne=530_ + 14, morphine=496_2, nalmefene=511 +_8 mg/dl) 
(Non-Diabetic saline= 142_+3, morphine= 138+_2, nalmefene 
= 148_+5 mg/dl) 
Short-Term Feedmg Studle~ 
The effect of morphine and nalmefene on food mtake m 
diabetic and non-diabetic control rats on day 1, day 2 and 
day 7 was analyzed by a 3-factor repeated measures 
ANOVA There were main effects of diabetic state, 
F(1,54)=11 72, of drug, F(2,54)--22 53, and of day of 
the study, F(2,108)=5 25 (all p ' s < 0  01) Also, there was a 
significant diabetic state x drug x day interaction Individ- 
ual group comparisons (LSD procedure) mdlcated that mor- 
phine stimulated 4 hour food mtake in the non-diabetic rats 
on days 1, 2, and 7, whereas morphme only stimulated food 
intake in the dmbetlc rats on day 7 (F~g 1) Nalmefene had 
no significant effect on 4 hour food intake, although the mean 
Intakes after nalmefene were consistently less than control 
means Twenty-four hour food intake was s]gmficantly de- 
creased m both d]abet]c and non-diabetic ammals following 
one injection (day 1) and following three reJections (day 1 + 
day 2) of morphine and nalmefene (Fig 2) 
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FIG 2 Twenty-four hour food intake m diabetic and non-dmbeUc 
rats following morphine (l0 mg/kg bid) and nalmefene (10 mg/kg bid) 
rejections on days 1 and 2 of the study -tp<0 05 compared to sahne 
controls for rats of same day and dmbet~c status 
Chrontc Drug Studtes 
The effect of morphine and nalmefene on average food 
retake and on body weight change over 22 days was analyzed 
by a 3-factor repeated measures ANOVA There were mam 
effects of dmbetlc state, F(1,54)=846 93, of drug, F(2,54)= 
9.34, and of day, F(7,378)=39 16 (a l lp ' s<0  001). There was 
a s]gmficant dmbeUc × drug mteractton, F(2,54)=5 22, 
p < 0  05, and a slgntficant dmbetlc × drug × day mteracUon, 
F(14,378)=2 86, p < 0  001 One factor ANOVA followed by 
LSD tests indicated that food retake was decreased by nal- 
mefene and morphine m the dmbetlc rats, whereas only mor- 
phine decreased feeding at some time points m the non- 
dmbetlc control rats (Fig. 3) 
Analysis of body weight data demonstrated main effects 
of diabetic state, F(1,54)=78 42, p < 0  001, and of day 
F(8,432)=63 85, p<0.001, but not of drug There was a slg- 
mficant interaction of dtabeUc state × drug × day, 
F(16,432)=1.814, p<0.05.  One factor ANOVA followed by 
the least slgnLfiCance d]fference test indicated that body 
weight was reduced due to morphine rejection only m the 
non-dmbetlc ammals (Fig. 4) Nalmefene failed to alter mean 
body weight m either group of rats Analysis of maxtmum 
percent body weight gain (maximum weight gaan or at least a 
negative weight change/initial body weight × 100) and 
maximum percent body weight loss (maximum weight loss or at 
least a negatwe weight change/initial body we~ght×100) 
substantmted the observaUon that morphine has a more potent 
effect in non-dmbet~c controls compared w~th diabetic rats 
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FIG 3 The effect of chrome mjecUon of morphine (10 mg/kg b~d) 
and nalmefene (10 mg/kg bid) on average food retake in diabetic (D) 
and non-dmbetlc (ND) rats *p <0 05 compared to sahne controls for 
rats of same day and dmbetlc status 
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FIG 4 The effect of chronic injection of morphine (10 mg/kg) and 
nalmefene (10 mg/kg) on body weight in dmbetlc (D) and non- 
dlabettc (ND) rats *p<0 05 compared to sahne controls for rats of 
same day and dmbet~c status 
weight lost by the rats treated with morphine was approx- 
imately 15%, in contrast to only above a 5% maximum body 
weight loss m the dmbet~c rats 
To integrate food retake and body weight data we calcu- 
lated a "feed effioency ratio" (change m body weight [e]ther 
(+) weight gain or ( - )  weight loss] from day 0 dwlded by the 
cumulative amount of food eaten) Morphine decreased the 
feed efficiency ratio m dmbeUcs as well as non-dmbetlcs, but 
had a more potent effect in the non-dmbetlc group (drug × 
dmbeUc state lnteractmn F(2,54)=3 432,p<0.05 (Fig. 6) In 
contrast, nalmefene failed to alter the feed efficiency ratto In 
non-dmbetlcs, but did so m the dmbet~cs 
DISCUSSION 
This study indicates that diabetic rats respond differently 
than non-dlabet~c control rats to the acute effects of mor- 
phine on food mtake as well as to the changes in food retake 
and body weight which occur followmg chrome morphine 
administration Morphine failed to stimulate short term food 
retake m diabetic animals following an lnmal exposure, 
whereas morphine stimulated feeding m non-dmbet]c con- 
trols rats after a single injection This might be secondary to 
the increased basal retake of food m the diabetics smce 
oplolds are less potent stimulators of feeding m a m m a l s  
chromcally food depraved [19] or during the nocturnal feed- 
lng period [22]. However, repeated exposure of diabetic 
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FIG 5 Maximum percent body weight loss (a) and percent body weight gain (b) in dmbetlc and non-diabetic rats following chromc injection 
of morphme (10 mg/kg bid) and nalmefene (10 mg/kg bid) tp<0 05 compared to sal,ne controls for rats of same day and dmbetlc status 
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animals to morphine ultimately resulted in enhanced food 
intake We have previously reported this "reverse- 
tolerance" effect in normal ammals [22] Nalmefene faded to 
alter short term food consumption m either group of rats, 
probably due to a floor effect In contrast to the short term 
studies, chronic administration of morphine to both dmbetlc 
and non-diabetic rats resulted m decreased cumulative food 
intake Also, morphine resulted in a more marked decrease 
in body weight in the non-dmbetlc animals The feed effi- 
ciency ratios also substantiated the latter finding, suggesting 
that diabetic rats were somewhat resistant to morphine's ef- 
fect on energy balance 
The above data are in concordance with those reported by 
Simon and his colleagues [29,30] They found that 
streptozotocln-mduced diabetic rats were less senslt~ve to 
the antlnooceptlve effects of morphine Recent data from 
the same laboratory indicates that hyperglycemia modifies 
the responses of guinea pig ileum and mouse vas deferens 
responses to normorphme [4.5] Prehmmary studies [31] indi- 
cate that glucose can enhance the bmdlng of naloxone to 
bram membranes It has also been shown that dmbetlc hu- 
mans display decreased pare thresholds and pare tolerance 
[22] In general, tt appears that dmbetlc ammals respond dif- 
ferently to the effects of morphine on both pam and food 
intake when compared to non-diabetic control ammals 
Relatively few studies have examined the effect of 
chromc admlmstratlon of oplold agomsts or antagonists on 
food intake and body weight In our study the long-acting 
oplold antagonist, nalmefene, faded to alter body weight m 
either dmbetlc or non-diabetic rats Nalmefene did not de- 
crease food intake m the non-dmbetic rats, but did decrease 
food intake shghtly in the diabetic rats McLaughhn and 
Bade [11] found that nalmefene decreased meal size and 
dally food intake, but increased meal frequency m Zucker 
rats and their lean httermates Body weight decreased dunng 
the first week of the study m the nalmefene treated animals 
compared with the sahne treated controls, however, subse- 
quent weight gain was greater in the nalmefene treated rats 
The weight loss was more marked m the obese Zucker rats 
Thus, McLaughhn and Bade [11 ] found only slight effects of 
nalmefene on body weight Naltrexone, when given twice a 
day at 10 mg/kg to genetically obese (ob/ob) mice decreased 
the rate of weight gain in these obese mice but had no effect 
on their lean httermates [23] From the latter studies ~t seems 
that op~old antagonism seems to affect energy balance more 
readily in obese animals Similarly, It appears that oplold 
antagonism is more potent in animals fed palatable foods 
Repeated injections of a zinc tannate preparation of 
naloxone abolishes diet-reduced obesity m rats fed a high fat 
cafeteria diet, whereas no effect of oploid blockade was 
noted in rats fed a low fat diet [15] Chromc naltrexone infu- 
sions (200 p.g/kg/hr) decreased appetite more effectively m 
rats fed chow plus 32% sucrose compared to those fed chow 
alone [16] Brands et al [2] also found that a zinc tannate salt 
of naloxone only decreased food intake during the first few 
days of the study and body weight during the first ten days of 
the study 
Shimomura et al [26] reported that lean mice given dady 
morphine injections decreased food retake McLaughhn and 
Baile [12]  reported that rats autolmmumzed against 
fl-endorphin increase both their food retake and body 
weight This suggests that chronically available endogenous 
fl-endorphm might result in a decrease m food retake and 
body weight Thls finding is m keeping with our previous 
study showing that peripherally infused beta-endorphm de- 
creased food retake [18] The present study indicates that 
normal rats chromcally treated with morphine lose weight 
and ingest somewhat less food suggesting that morphine's 
effect on body weight could be due to increased energy ex- 
penditure, rather than secondary to its effects on feeding 
Also, nalmefene faded to decrease body weight in dmbetlc 
ammals, although food retake was decreased However. it is 
difficult to generahze these effects of morphine and/or 
fl-endorphm to all oplolds 
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FIG 6 The effect of chronic admmlstraUon of morphine (10 mg/kg 
bid) and nalmefene (10 mg/kg bid) on feed efficiency in diabetic and 
non-diabetic rats +p<0 05 for rats of same day and diabetic status 
The dec reased  feed eff ic iency noted  with chronic  inJec- 
tion o f  morph ine  suggests  an effect  on energy  conse rva t ion  
Morph ine  seems  to have dec reased  body weight  to a grea ter  
ex t en t  than  can be accoun ted  for  by food intake alone,  par- 
t icularly in the non-dmbet lc  animals Chronic  na loxone  re- 
j ec t ion  has been  repor ted  by several  invest igators  to increase 
oxygen  consumpt ion  [14,15] H o w e v e r ,  Marks -Kaufman  et 
al [16] found that  al though nal t rexone  t r ea tmen t  a l tered the 
resp i ra tory  quot ient ,  it had no effect  on total oxygen  con- 
sumpt ion  Oplolds are also k n o w n  to affect  hpld metabol i sm 
For  example ,  Richter  et al [24] demons t r a t ed  that  
/3-11potropm st imulated hpolys ls  in rabbi ts  
Thus ,  the p resen t  data  indicate that  morph ine ,  w h e n  in- 
j e c t ed  chromcal ly ,  can alter body  weight  The effect  o f  mor-  
phine on body weight  is different  in dmbet ic  animals w h e n  
co mp ared  to non-diabet ic  cont ro ls  In general ,  diabetic 
animals appear  to be less sensi t ive to the acute effects  of  
morph ine  on food intake and the effects  of  ch romc  adminis-  
t rat ion o f  morphine  on body  weight  
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